Psycheceutical Bioscience Stock

Psycheceutical Bioscience EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Psycheceutical Bioscience (BWVI) as of Aug 14, 2026 is -0.01. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -0.09 — a change of -87.67% (higher).

EV/EBIT

-0.01

YoY

-87.67%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Psycheceutical Bioscience is 2026 -0.01 . EV/EBIT (Enterprise Value to EBIT) of Psycheceutical Bioscience was 2025 -0.09 . It decreases by -87.67% higher compared to the previous year.

The Psycheceutical Bioscience EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2015
0.00 base
Jan 1, 2016
0.00 base
Jan 1, 2017
0.00 base
Jan 1, 2018
0.00 base
Jan 1, 2019
0.00 base
Jan 1, 2020
0.00 base
Jan 1, 2021
0.00 base
Jan 1, 2022
0.00 base
YEARPRICE-TO-EBIT
2022 -
2021 -
2020 -
2019 -
2018 -
2017 -
2016 -
2015 -
2014 -
2011 -
2010 -
2009 -
2008 -
2007 -
2006 -
2005 -
2004 -
2003 -
Access this data via the Eulerpool API

Psycheceutical Bioscience Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Psycheceutical Bioscience's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Psycheceutical Bioscience's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Psycheceutical Bioscience's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Psycheceutical Bioscience grows earnings faster than its peers.

Psycheceutical Bioscience Stock analysis

What does Psycheceutical Bioscience do? Blue Water Ventures International Inc (BWVI) is a company specialized in the exploration of treasures on the seabed. The company's history dates back to 2005 when founder Keith Webb had the idea to search for lost treasures at sea. Since then, BWVI has become a leading company in the industry. BWVI's business model is based on treasure hunting at sea. The company uses state-of-the-art technologies to locate shipwrecks and other treasures on the ocean floor. Once a treasure is discovered, BWVI forms partnerships with other companies to recover and market the treasure. The profits from the sale of the treasure are divided between BWVI and its partners. BWVI also owns and operates its own online auction where antiques such as jewelry, historical coins, and artifacts are exhibited and sold. The auction is an important part of BWVI's business model and offers customers the opportunity to acquire unique treasures. The company has various divisions all focused on underwater treasure hunting. One division focuses on the exploration and search for sunken ships and artifacts. Another division focuses on the exploration of sites where potential treasures are suspected. BWVI utilizes state-of-the-art technologies such as sonar and magnetic sensors to locate underwater treasures. BWVI also offers services such as archiving and restoration of artifacts. The company collaborates with experts to ensure the best possible preservation and restoration of historical artifacts. BWVI's portfolio includes a variety of products and services. These include unique treasures such as jewels, gold and silver coins, ceramics, and other artifacts recovered from historical shipwrecks. Additionally, the company also offers merchandising items such as t-shirts, caps, and keychains featuring the BWVI logo. Recently, BWVI has also begun to explore other business areas. The company has partnered with a CBD product manufacturer and will be bringing CBD products to the market. Furthermore, BWVI has plans to enter the field of renewable energies, particularly tidal power plants. Overall, BWVI has undergone an impressive development in recent years. The company has established itself as a leading player in underwater treasure hunting and offers its customers a unique experience. With a strong portfolio of products and services and a clear vision for the future, BWVI is well-positioned to continue its success in the future. Psycheceutical Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psycheceutical Bioscience stock

EV/EBIT (Enterprise Value to EBIT) of Psycheceutical Bioscience is -0.01 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Psycheceutical Bioscience changed from -0.09 to -0.01, representing a -87.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Psycheceutical Bioscience since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Psycheceutical Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Psycheceutical Bioscience

All Key Metrics — Psycheceutical Bioscience